ZA967562B - Materials and methods relating to the attachment and display of substances on cell surfaces. - Google Patents

Materials and methods relating to the attachment and display of substances on cell surfaces.

Info

Publication number
ZA967562B
ZA967562B ZA9607562A ZA967562A ZA967562B ZA 967562 B ZA967562 B ZA 967562B ZA 9607562 A ZA9607562 A ZA 9607562A ZA 967562 A ZA967562 A ZA 967562A ZA 967562 B ZA967562 B ZA 967562B
Authority
ZA
South Africa
Prior art keywords
substances
attachment
display
materials
cell surfaces
Prior art date
Application number
ZA9607562A
Other languages
English (en)
Inventor
Lothar Steidler
Erik Remaut
Jeremy Mark Wells
Original Assignee
Lothar Steidler
Erik Remaut
Jeremy Mark Wells
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lothar Steidler, Erik Remaut, Jeremy Mark Wells filed Critical Lothar Steidler
Publication of ZA967562B publication Critical patent/ZA967562B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Adhesive Tapes (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
  • Sheet Holders (AREA)
ZA9607562A 1995-09-07 1996-09-06 Materials and methods relating to the attachment and display of substances on cell surfaces. ZA967562B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9518323.2A GB9518323D0 (en) 1995-09-07 1995-09-07 Materials and methods relating to the attachment and display of substances on cell surfaces

Publications (1)

Publication Number Publication Date
ZA967562B true ZA967562B (en) 1998-03-06

Family

ID=10780370

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9607562A ZA967562B (en) 1995-09-07 1996-09-06 Materials and methods relating to the attachment and display of substances on cell surfaces.

Country Status (17)

Country Link
US (1) US6190662B1 (de)
EP (1) EP0848756B1 (de)
JP (1) JP4180111B2 (de)
KR (1) KR19990044528A (de)
CN (1) CN1201493A (de)
AT (1) ATE270337T1 (de)
AU (1) AU729449B2 (de)
BR (1) BR9610133A (de)
CA (1) CA2231372A1 (de)
DE (1) DE69632827T2 (de)
GB (1) GB9518323D0 (de)
HK (1) HK1014337A1 (de)
MX (1) MX9801864A (de)
NO (1) NO980976L (de)
NZ (1) NZ316580A (de)
WO (1) WO1997009437A1 (de)
ZA (1) ZA967562B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821088A (en) * 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
DE19735105A1 (de) * 1997-08-13 1999-03-04 Univ Albert Ludwigs Freiburg Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen
EP0916726A1 (de) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1012245A1 (de) * 1998-06-25 2000-06-28 Korea Green Cross Corporation Oberflächenexpressionssystem von hepatitis b virus oberflächenantigen und kernantigen von hepatitis c virus unter verwendung von eis-kern protein
KR100313135B1 (ko) 1999-02-22 2001-11-05 윤덕용 세포 표면 발현 모체로서의 대장균 유래 세포외막 단백질 ｃ(ｏ
PT1739178E (pt) * 1999-07-05 2010-11-17 Actogenix Nv Libertação de péptidos trifólios
IL154284A0 (en) * 2000-09-25 2003-09-17 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
AU1120102A (en) * 2000-11-02 2002-05-15 Univ Singapore AopB gene, protein, homologs, fragments and variants thereof, and their use for cell surface display
EP1239032A1 (de) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Milchsäurebakterien als Mitteln zur Behandlung und Vorbeugung von Allergie
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
JP2005529622A (ja) * 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
US7527966B2 (en) * 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
JP2006520584A (ja) 2002-11-08 2006-09-14 アブリンクス エン．ヴェー． 安定化単一ドメイン抗体
BRPI0316092B8 (pt) 2002-11-08 2021-05-25 Ablynx Nv anticorpos de domínio único direcionados contra o fator de necrose tumoral alfa e usos para os mesmos
WO2004046346A2 (en) * 2002-11-15 2004-06-03 Vib Vzw Self-containing lactobacillus strain
CN101076599A (zh) * 2003-01-29 2007-11-21 奥赛尔股份有限公司 细菌中生物学活性蛋白质的表面表达
CA2539452C (en) * 2003-09-17 2013-10-29 Guava Technologies, Inc. Compositions and methods for analysis of target analytes
US7456011B2 (en) * 2005-01-12 2008-11-25 Osel, Inc. Modified cyanovirin-n polypeptide
EP2119450B1 (de) 2005-11-29 2013-02-13 Actogenix N.V. Induktion von mukosaler Toleranz für pankreatische Beta-Inselzell-Autoantigene
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
EP1972350A1 (de) * 2007-03-20 2008-09-24 Rijksuniversiteit Groningen Duales Targeting-System
WO2009137763A2 (en) * 2008-05-08 2009-11-12 Emory University Methods and compositions for the display of polypeptides on the pili of gram-positive bacteria
JP2012504116A (ja) * 2008-09-29 2012-02-16 アクトジェニックス・エヌブイ 粘膜での微生物のコロニー形成の低減
WO2014039746A1 (en) 2012-09-07 2014-03-13 Emory University Hiv immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto
EP2897638A1 (de) 2012-09-24 2015-07-29 Montana State University-Bozeman Rekombinanter lactococcus lactis zur expression des escherichia coli-kolonisationsfaktor-antigens i (cfa/i) fimbriae und verfahren zu deren verwendung
JP2024500837A (ja) * 2020-12-23 2024-01-10 チャン ザッカーバーグ バイオハブ， インコーポレイテッド 抗原特異的ｔ細胞を惹起するように操作された細菌

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616686A (en) 1990-05-11 1997-04-01 The Rockefeller University Polypeptide of a hybrid surface protein by bacteria
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
AU674311B2 (en) * 1992-03-13 1996-12-19 Rockefeller University, The Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria

Also Published As

Publication number Publication date
GB9518323D0 (en) 1995-11-08
HK1014337A1 (en) 1999-09-24
BR9610133A (pt) 1999-12-21
JPH11511983A (ja) 1999-10-19
US6190662B1 (en) 2001-02-20
NO980976D0 (no) 1998-03-06
DE69632827T2 (de) 2005-07-07
CA2231372A1 (en) 1997-03-13
NO980976L (no) 1998-05-06
KR19990044528A (ko) 1999-06-25
CN1201493A (zh) 1998-12-09
DE69632827D1 (de) 2004-08-05
AU729449B2 (en) 2001-02-01
ATE270337T1 (de) 2004-07-15
JP4180111B2 (ja) 2008-11-12
WO1997009437A1 (en) 1997-03-13
EP0848756A1 (de) 1998-06-24
AU6884496A (en) 1997-03-27
EP0848756B1 (de) 2004-06-30
MX9801864A (es) 1998-11-29
NZ316580A (en) 1999-09-29

Similar Documents

Publication Publication Date Title
GB9518323D0 (en) Materials and methods relating to the attachment and display of substances on cell surfaces
AU5099293A (en) CD27 ligand
AU5919894A (en) Detecting biological activities in culture vials
HUP0000317A3 (en) Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
CA2160131A1 (en) New Bacillus Thuringiensis Strains and Their Insecticidal Proteins
SG47883A1 (en) N-terminally extended proteins expressed in yeast
FI943389A (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
CA2153068A1 (en) Enhancer sequence for modulating expression in epithelial cells
BR9607583B1 (pt) plasmìdios procarióticos recombinantes.
IE822488L (en) Cloning vectors for use in streptomyces and related¹organisms
AU3502089A (en) Bacillus thuringiensis transformation
AU6889794A (en) Water-repellent earth material, and methods of making and using the same
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
EP0669396A4 (de) Neuartige polypeptide und dafür kodierende dna.
AU7116394A (en) Culture medium for recombinant yeasts
AU1196295A (en) Improvements in or relating to writing instruments
AU6496094A (en) Tumor-associated antigens recognized by t cells and the uses of these antigens
CA2337088A1 (en) Methods and constructs for protein expression
AU7324094A (en) Cell surface protein present on nk (natural killer cells) named dx1
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
AU1305097A (en) Protein induced by deprenyl$m(3)
Stone White House to take crack at reinventing science.
AU6184990A (en) Arginine-rich yeast
AU7744498A (en) Biocontrol agents for use in agriculture